Skip to main content
. 2015 Nov 18;48(1):55–66. doi: 10.3892/ijo.2015.3251

Table III.

Association between RASSF1A promoter methylation, protein expression of RASSF1A and RASSF1C and data of patients.

Patients/specimens/qPCR results Variables, n RASSF1A promoter methylation and protein assessment RASSF1C protein assessment


Unmethylation vs. hypermethylation (%) Protein level relative to control samples (%) Protein level relative to control samples (%)



Unmethylated (%) Hypermethylated (%) P-valuea Low (≤10.09b) High (>10.09b) P-valuea Low (>3.03b) High (≤3.03b) P-valuea
Age (years)
 ≤62 (n=29) 17 (29) 12 (21) 1.00 24 (41) 5 (9) 0.35 24 (41) 5 (9) 1.00
 >62 (n=29) 18 (31) 11 (19) 20 (34) 9 (16) 24 (41) 5 (9)
Gender
 Female (n=280) 14 (24) 14 (24) 0.18 22 (38) 6 (10) 0.76 24 (41) 4 (8) 0.73
 Male (n=30) 21 (36) 9 (16) 22 (38) 8 (14) 24 (41) 6 (10)
Tumor size (cm)
 ≤7 (n=34) 19 (33) 15 (26) 0.43 25 (43) 9 (16) 0.76 28 (47) 7 (12) 0.51
 >7 (n=24) 16 (28) 8 (13) 19 (33) 5 (8) 21 (36) 3 (5)
Fuhrman's histological grade
 1 + 2 (n=25) 17 (29) 8 (14) 0.41 15 (26) 10 (17) 0.028 19 (33) 6 (10) 0.3
 3 + 4 (n=33) 18 (31) 15 (26) 29 (50) 4 (7) 29 (50) 4 (7)
TNM stage groupingc
 Non-metastatic (n=32) 24 (41) 8 (14) 0.01 20 (33) 12 (20) 0.006 27 (44) 5 (8) 1.00
 Metastatic n=26 11 (19) 15 (26) 27 (41) 2 (6) 24 (40) 5 (8)
RASSF1A/RASSF1C qPCR expression level
 Low (≤0.266 for RASSF1A) or (≥0.19 for RASSF1C) 17 (29) 16 (28) 0.17 31 (53) 2 (3) 0.0004 20 (34) 0 0.01
 High (>0.266 for RASSF1A) or (<0.19 for RASSF1C) 18 (31) 7 (12) 13 (22) 12 (21) 28 (48) 10 (18)
a

P-values were calculated by Fisher's 2×2 test;

b

protein content was expressed in densitometric units;

c

TNM division as described in Table I.